Intravenous thrombolysis in ischemic stroke: clinical predictors of efficacy and safety
Introduction. Systemic thrombolysis with recombinant tissue plasminogen activator is the gold standard of reperfusion therapy, having the maximum level of evidence in European and North American guidelines for the treatment of patients with acute ischemic stroke (IS). Objective: to determine factors...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Research Center of Neurology
2019-03-01
|
| Series: | Анналы клинической и экспериментальной неврологии |
| Subjects: | |
| Online Access: | https://annaly-nevrologii.com/journal/pathID/article/viewFile/573/460 |